Minerva Surgical Inc. (UTRS) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Minerva Surgical Inc. (UTRS:NASDAQ), powered by AI.

Current Price
$0.00
Market Cap
144
Sector
Healthcare
What is the Minerva Surgical Inc. stock price forecast?

Minerva Surgical Inc. is currently trading at $0.00. View real-time AI analysis on Alpha Lenz.

What is Minerva Surgical Inc. insider trading activity?

View the latest insider trading data for Minerva Surgical Inc. on Alpha Lenz.

What is Minerva Surgical Inc.'s P/E ratio?

View Minerva Surgical Inc.'s valuation metrics on Alpha Lenz.

Minerva Surgical Inc.

$0.00
NASDAQUTRS
Ask about Minerva Surgical Inc.'s future dividend policy...
Alpha Chat Insight

Minerva Surgical Inc.'s ROE is -111.3%. Explore profitability and growth together.

Ask for details

Company Overview

Minerva Surgical Inc. is a medical technology company specializing in the development, manufacturing, and commercialization of minimally invasive devices for women's uterine health. Its primary focus is on providing advanced solutions for the treatment of abnormal uterine bleeding (AUB), a prevalent condition that can significantly impact women's quality of life. Minerva Surgical offers a comprehensive suite of products, including endometrial ablation systems and advanced tissue removal devices, designed as alternatives to more invasive procedures like hysterectomy. These products utilize technologies such as bipolar radiofrequency energy and enable direct intrauterine visualization, supporting safer and more precise treatments in a variety of care settings, from hospitals to physician offices. By prioritizing uterus-sparing and non-hormonal interventions, Minerva Surgical aims to address the root causes of AUB while minimizing recovery time and preserving reproductive anatomy. The company's commitment to clinical excellence, innovation, and support for gynecologic practitioners positions it as a significant player in women’s health and the broader medical device sector.

CEOMr. Todd Usen
SectorHealthcare
IndustryMedical Devices
Employees174

Company Statistics

(FY 2022)

Profile

Market Cap$144.00
Revenue$50.29M
Shares Out0.00
Employees174

Margins

Gross54.17%
EBITDA-39.91%
Operating-61.44%
Pre-Tax-67.80%
Net-67.83%

Valuation

P/EN/A
P/BN/A
EV/SalesN/A
EV/EBITDA-1.63
P/FCFN/A

Growth (CAGR)

Rev 3YrN/A
Rev 5YrN/A
Op Inc 3YrN/A
Op Inc 5YrN/A
Net Inc 3YrN/A
Net Inc 5YrN/A

Returns

ROA-37.08%
ROE-111.32%
ROIC-33.57%

Financial Health

Cash & Cash Equivalents$6.94M
Net Debt$44.78M
Debt/Equity301.02%
Interest CovN/A
Ask Alpha Chat

Frequently Asked Questions

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Minerva Surgical Inc. (Healthcare) Stock Forecast & Analysis $0.00 | Alpha Lenz